Quantinno Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Quantinno Capital Management's MDGL Position: Q3 2026 in Review
Quantinno Capital Management increased its Madrigal Pharmaceuticals (MDGL) stake by 51% in Q3 2026, buying an estimated $687K and bringing the position to 3,841 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.
Quantinno Capital Management first reported a position in MDGL in Q1 2025 and has held it in 5 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Quantinno Capital Management held 3,841 shares of Madrigal Pharmaceuticals worth $1.94M as of Q3 2026.
- Quantinno Capital Management bought 1,299 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $687K.
- Madrigal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2217 holding.
- Quantinno Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.